Reports for CIPROFLOXACIN
Ingredient
CIPROFLOXACIN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 0.1% 0.3% | SUSPENSION | Resolved | 2024-01-16 | 2024-01-31 | 216164 |
| SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 0.1% 0.3% | SUSPENSION | Resolved | 2025-04-28 | 2025-05-13 | 255894 |
| TARO-CIPROFLOX | 250MG | TABLET | Resolved | 2023-02-01 | 2024-05-09 | 183077 |
| TARO-CIPROFLOX | 500MG | TABLET | Resolved | 2021-12-07 | 2022-08-19 | 150659 |
| TARO-CIPROFLOX | 500MG | TABLET | Resolved | 2023-01-20 | 2023-08-16 | 182031 |
| TARO-CIPROFLOX | 750MG | TABLET | Resolved | 2023-02-01 | 2024-05-09 | 183082 |
| TARO-CIPROFLOXACIN/DEXAMETHASONE | 0.1% 0.3% | SUSPENSION | Resolved | 2021-12-07 | 2024-09-27 | 150683 |
| TARO-CIPROFLOXACIN/DEXAMETHASONE | 0.1% 0.3% | SUSPENSION | Resolved | 2025-01-29 | 2025-04-04 | 249020 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CIPRO XL | 1000MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE) | Discontinued | 2022-01-20 | 2022-03-02 | 153201 |
| CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4924 |
| CIPROFLOXACIN INJECTION | 2MG | SOLUTION | Discontinued | 2020-07-21 | 2020-08-17 | 120710 |
| CIPROFLOXACIN INJECTION USP | 2MG | SOLUTION | Discontinued | 2022-09-27 | 2022-09-28 | 170299 |
| CIPROFLOXACIN INJECTION USP | 2MG | SOLUTION | Discontinued | 2022-09-27 | 2022-10-01 | 170302 |
| DOM-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2020-11-13 | 2020-11-13 | 128343 |
| MYLAN-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2018-06-04 | 2018-07-04 | 51275 |
| MYLAN-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2018-06-04 | 2018-07-04 | 51283 |
| MYLAN-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2017-08-24 | 2017-12-02 | 20278 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2023-09-20 | 2023-09-20 | 204854 |